Comments
Loading...
Sight Sciences Analyst Ratings and Price Targets | NASDAQ:SGHT | Benzinga
Sight Sciences Inc has a consensus price target of $3.93 based on the ratings of 9 analysts. The high is $5 issued by UBS on January 27, 2025. The low is $2.5 issued by Lake Street on March 6, 2025. The 3 most-recent analyst ratings were released by Lake Street, Stifel, and Piper Sandler on March 6, 2025, respectively. With an average price target of $3.33 between Lake Street, Stifel, and Piper Sandler, there's an implied 43.68% upside for Sight Sciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Lake Street
Stifel
Piper Sandler
Citigroup
UBS
1calculated from analyst ratings
Analyst Ratings for Sight Sciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/09/2025 | Buy Now | — | Needham | David Saxon51% | — | Reiterates | Hold → Hold | Get Alert |
| 03/06/2025 | Buy Now | 7.76% | Lake Street | Frank Takkinen35% | $3 → $2.5 | Maintains | Hold | Get Alert |
| 03/06/2025 | Buy Now | 72.41% | Stifel | Thomas Stephan36% | $5 → $4 | Maintains | Buy | Get Alert |
| 03/06/2025 | Buy Now | 50.86% | Piper Sandler | Matt O'Brien49% | $5.5 → $3.5 | Maintains | Neutral | Get Alert |
| 03/06/2025 | Buy Now | — | Needham | David Saxon51% | — | Reiterates | Hold → Hold | Get Alert |
| 03/04/2025 | Buy Now | 29.31% | Citigroup | Joanne Wuensch75% | $4.6 → $3 | Maintains | Neutral | Get Alert |
| 02/06/2025 | Buy Now | 115.52% | Stifel | Thomas Stephan36% | $6 → $5 | Maintains | Buy | Get Alert |
| 01/27/2025 | Buy Now | 115.52% | UBS | Danielle Antalffy58% | $5.5 → $5 | Maintains | Buy | Get Alert |
| 01/15/2025 | Buy Now | 29.31% | Lake Street | Frank Takkinen35% | $5 → $3 | Maintains | Hold | Get Alert |
| 01/14/2025 | Buy Now | — | Needham | David Saxon51% | — | Reiterates | Hold → Hold | Get Alert |
| 12/11/2024 | Buy Now | 98.28% | Citigroup | Joanne Wuensch75% | $5.8 → $4.6 | Maintains | Neutral | Get Alert |
| 12/06/2024 | Buy Now | 137.07% | UBS | Danielle Antalffy58% | → $5.5 | Initiates | → Buy | Get Alert |
| 11/11/2024 | Buy Now | 115.52% | Morgan Stanley | Cecilia Furlong51% | $7 → $5 | Maintains | Equal-Weight | Get Alert |
| 11/08/2024 | Buy Now | 137.07% | Piper Sandler | Matt O'Brien49% | $6 → $5.5 | Reiterates | Neutral → Neutral | Get Alert |
| 11/08/2024 | Buy Now | — | Needham | David Saxon51% | — | Reiterates | → Hold | Get Alert |
| 08/21/2024 | Buy Now | 331.03% | Lake Street | Frank Takkinen35% | → $10 | Initiates | → Buy | Get Alert |
| 08/02/2024 | Buy Now | — | Needham | David Saxon51% | — | Reiterates | → Hold | Get Alert |
| 07/15/2024 | Buy Now | 180.17% | Morgan Stanley | Cecilia Furlong51% | $5.4 → $6.5 | Maintains | Equal-Weight | Get Alert |
| 07/10/2024 | Buy Now | 180.17% | Citigroup | Joanne Wuensch75% | $6 → $6.5 | Maintains | Neutral | Get Alert |
| 05/03/2024 | Buy Now | 158.62% | Piper Sandler | Matt O'Brien49% | $5 → $6 | Reiterates | Neutral → Neutral | Get Alert |
| 05/03/2024 | Buy Now | — | Needham | David Saxon51% | — | Reiterates | → Hold | Get Alert |
| 04/10/2024 | Buy Now | — | Needham | David Saxon51% | — | Reiterates | → Hold | Get Alert |
| 03/08/2024 | Buy Now | 201.72% | Stifel | Thomas Stephan36% | $6 → $7 | Maintains | Buy | Get Alert |
| 12/04/2023 | Buy Now | 72.41% | Morgan Stanley | Cecilia Furlong51% | $3 → $4 | Maintains | Equal-Weight | Get Alert |
| 11/08/2023 | Buy Now | 29.31% | Morgan Stanley | Cecilia Furlong51% | $4 → $3 | Maintains | Equal-Weight | Get Alert |
| 09/18/2023 | Buy Now | 115.52% | Stifel | Thomas Stephan36% | $11 → $5 | Maintains | Buy | Get Alert |
| 09/15/2023 | Buy Now | 72.41% | Citigroup | Joanne Wuensch75% | $8 → $4 | Maintains | Neutral | Get Alert |
| 09/13/2023 | Buy Now | 93.97% | B of A Securities | Bob Hopkins48% | $10 → $4.5 | Downgrade | Neutral → Underperform | Get Alert |
| 09/13/2023 | Buy Now | 72.41% | Morgan Stanley | Cecilia Furlong51% | $8.4 → $4 | Maintains | Equal-Weight | Get Alert |
| 09/12/2023 | Buy Now | 93.97% | B of A Securities | Bob Hopkins48% | $10 → $4.5 | Downgrade | Neutral → Underperform | Get Alert |
| 09/12/2023 | Buy Now | — | William Blair | Andrew Brackmann26% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 09/12/2023 | Buy Now | 137.07% | Piper Sandler | Matt O'Brien49% | $15 → $5.5 | Downgrade | Overweight → Neutral | Get Alert |
| 08/24/2023 | Buy Now | 262.07% | Morgan Stanley | Cecilia Furlong51% | $12 → $8.4 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/21/2023 | Buy Now | 244.83% | Citigroup | Joanne Wuensch75% | $9 → $8 | Maintains | Neutral | Get Alert |
| 08/04/2023 | Buy Now | 417.24% | Morgan Stanley | Cecilia Furlong51% | $15 → $12 | Maintains | Overweight | Get Alert |
| 07/11/2023 | Buy Now | 287.93% | Citigroup | Joanne Wuensch75% | $15 → $9 | Downgrade | Buy → Neutral | Get Alert |
| 07/10/2023 | Buy Now | 287.93% | Citigroup | Joanne Wuensch75% | $15 → $9 | Downgrade | Buy → Neutral | Get Alert |
| 06/26/2023 | Buy Now | 460.34% | Stifel | Thomas Stephan36% | $15 → $13 | Maintains | Buy | Get Alert |
| 06/12/2023 | Buy Now | — | Needham | David Saxon51% | — | Maintains | Hold | Get Alert |
| 06/06/2023 | Buy Now | 331.03% | B of A Securities | Bob Hopkins48% | $13 → $10 | Maintains | Buy | Get Alert |
| 01/06/2023 | Buy Now | 546.55% | Morgan Stanley | Cecilia Furlong51% | $11 → $15 | Maintains | Overweight | Get Alert |
| 01/06/2023 | Buy Now | 546.55% | Stifel | Thomas Stephan36% | $10 → $15 | Upgrade | Hold → Buy | Get Alert |
| 12/12/2022 | Buy Now | 546.55% | Citigroup | Joanne Wuensch75% | $10 → $15 | Maintains | Buy | Get Alert |
| 11/11/2022 | Buy Now | 374.14% | Morgan Stanley | Cecilia Furlong51% | $10 → $11 | Maintains | Overweight | Get Alert |
| 10/11/2022 | Buy Now | 331.03% | Morgan Stanley | Cecilia Furlong51% | $14 → $10 | Maintains | Overweight | Get Alert |
| 10/04/2022 | Buy Now | — | Needham | David Saxon51% | — | Initiates | → Hold | Get Alert |
| 08/12/2022 | Buy Now | 503.45% | Morgan Stanley | Cecilia Furlong51% | $17 → $14 | Maintains | Overweight | Get Alert |
| 08/12/2022 | Buy Now | 546.55% | Piper Sandler | Matt O'Brien49% | $17 → $15 | Maintains | Overweight | Get Alert |
| 07/26/2022 | Buy Now | 331.03% | Stifel | Thomas Stephan36% | → $10 | Initiates | → Hold | Get Alert |
| 07/15/2022 | Buy Now | 632.76% | Morgan Stanley | Cecilia Furlong51% | $18 → $17 | Maintains | Overweight | Get Alert |
| 05/11/2022 | Buy Now | 675.86% | Morgan Stanley | Cecilia Furlong51% | $27 → $18 | Maintains | Overweight | Get Alert |
| 05/11/2022 | Buy Now | 632.76% | Piper Sandler | Matt O'Brien49% | $23 → $17 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Sight Sciences (SGHT) stock?
The latest price target for Sight Sciences (NASDAQ:SGHT) was reported by Needham on April 9, 2025. The analyst firm set a price target for $0.00 expecting SGHT to fall to within 12 months (a possible -100.00% downside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Sight Sciences (SGHT)?
The latest analyst rating for Sight Sciences (NASDAQ:SGHT) was provided by Needham, and Sight Sciences reiterated their hold rating.
When was the last upgrade for Sight Sciences (SGHT)?
The last upgrade for Sight Sciences Inc happened on January 6, 2023 when Stifel raised their price target to $15. Stifel previously had a hold for Sight Sciences Inc.
When was the last downgrade for Sight Sciences (SGHT)?
The last downgrade for Sight Sciences Inc happened on September 13, 2023 when B of A Securities changed their price target from $10 to $4.5 for Sight Sciences Inc.
When is the next analyst rating going to be posted or updated for Sight Sciences (SGHT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sight Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sight Sciences was filed on April 9, 2025 so you should expect the next rating to be made available sometime around April 9, 2026.
Is the Analyst Rating Sight Sciences (SGHT) correct?
While ratings are subjective and will change, the latest Sight Sciences (SGHT) rating was a reiterated with a price target of $0.00 to $0.00. The current price Sight Sciences (SGHT) is trading at is $2.38, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.